Full View

Pyridoxamine Reverts Methylglyoxal‐induced Impairment of Survival Pathways During Heart Ischemia

F Almeida, D Santos‐Silva, T Rodrigues… - Cardiovascular …, 2013 - Wiley Online Library
Background and aims Increased levels of advanced glycation end‐products (AGE) and their
precursors, such as methylglyoxal (MG), in patients with diabetes may account for impaired …
被引用次数：27 相关文章

Pyridoxamine reverts methylglyoxal-induced impairment of survival pathways during heart ischemia.

F Almeida, D Santos-Silva, T Rodrigues… - Cardiovascular …, 2013 - europepmc.org
Methods Wistar rats were subjected to MG administration (WM), MG plus pyridoxamine
(WMPyr), or no treatment (W). Half of the hearts from each group were submitted to ischemia …

Pyridoxamine reverts methylglyoxal-induced impairment of survival pathways during heart ischemia

F Almeida, D Santos-Silva… - Cardiovascular …, 2013 - pubmed.ncbi.nlm.nih.gov
Background and aims Increased levels of advanced glycation end-products (AGE) and their
precursors, such as methylglyoxal (MG), in patients with diabetes may account for impaired …

Pyridoxamine Reverts Methylglyoxal-induced Impairment of Survival Pathways During Heart Ischemia.

F Almeida, D Santos‐Silva… - Cardiovascular …, 2013 - search.ebscohost.com
Background and aims Increased levels of advanced glycation end-products (AGE) and their
precursors, such as methylglyoxal (MG), in patients with diabetes may account for impaired …

Pyridoxamine Reverts Methylglyoxal‐induced Impairment of Survival Pathways During Heart Ischemia

F Almeida, D Santos‐Silva, T Rodrigues… - Cardiovascular …, 2013 - infona.pl
Background and aims Increased levels of advanced glycation end‐products (AGE) and their
precursors, such as methylglyoxal (MG), in patients with diabetes may account for impaired …